Literature DB >> 1329623

Increased sensitivity of Candida albicans cells accumulating 14 alpha-methylated sterols to active oxygen: possible relevance to in vivo efficacies of azole antifungal agents.

O Shimokawa1, H Nakayama.   

Abstract

The sensitivity of Candida albicans cells to killing by hydrogen peroxide was found to increase markedly when they were grown in the presence of sub-growth-inhibitory concentrations of the azole drug clotrimazole (CTZ). A superoxide anion-generating system consisting of xanthine and xanthine oxidase also killed such CTZ-treated cells more efficiently than control cells, but this seemed to be accounted for by hydrogen peroxide secondarily formed from superoxide anion as judged by the effect of catalase and superoxide dismutase. The increased sensitivity to hydrogen peroxide was considered to be attributable to the inhibition of 14 alpha-demethylation of ergosterol biosynthesis by CTZ, since a 14 alpha-demethylation-deficient mutant of C. albicans exhibited a similar phenotype. It is suggested that the in vivo efficacy of azole antifungal agents against C. albicans infection is at least partially due to the sensitization of the fungal cells to the oxygen-dependent microbicidal system of the phagocyte.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1329623      PMCID: PMC192020          DOI: 10.1128/AAC.36.8.1626

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Xanthine oxidase. IV. Participation of iron in internal electron transport.

Authors:  I FRIDOVICH; P HANDLER
Journal:  J Biol Chem       Date:  1958-12       Impact factor: 5.157

2.  Deficient utilization of succinate in a sterol 14 alpha-demethylation mutant of Candida albicans.

Authors:  O Shimokawa; H Nakayama
Journal:  J Med Vet Mycol       Date:  1991

3.  Biochemical effects of miconazole on fungi. II. Inhibition of ergosterol biosynthesis in Candida albicans.

Authors:  H van den Bossche; G Willemsens; W Cools; W F Lauwers; L Le Jeune
Journal:  Chem Biol Interact       Date:  1978-04       Impact factor: 5.192

Review 4.  Candida albicans: biology, genetics, and pathogenicity.

Authors:  M G Shepherd; R T Poulter; P A Sullivan
Journal:  Annu Rev Microbiol       Date:  1985       Impact factor: 15.500

Review 5.  The respiratory burst of phagocytes.

Authors:  B M Babior
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

6.  Interaction of Candida albicans with human leukocytes and serum.

Authors:  R I Lehrer; M J Cline
Journal:  J Bacteriol       Date:  1969-06       Impact factor: 3.490

7.  Superoxide dismutases of Escherichia coli: intracellular localization and functions.

Authors:  E M Gregory; F J Yost; I Fridovich
Journal:  J Bacteriol       Date:  1973-09       Impact factor: 3.490

8.  Accumulation of 14-methyl sterols and defective hyphal growth in Candida albicans.

Authors:  O Shimokawa; Y Kato; H Nakayama
Journal:  J Med Vet Mycol       Date:  1986-08

9.  Increased drug sensitivity in Candida albicans cells accumulating 14-methylated sterols.

Authors:  O Shimokawa; Y Kato; H Nakayama
Journal:  J Med Vet Mycol       Date:  1986-12

10.  The activity of ketoconazole in mixed cultures of leukocytes and Candida albicans.

Authors:  M de Brabander; F Aerts; J van Cutsem; H van den Bossche; M Borgers
Journal:  Sabouraudia       Date:  1980-09
View more
  23 in total

1.  Miconazole induces fungistasis and increases killing of Candida albicans subjected to photodynamic therapy.

Authors:  Sara B Snell; Thomas H Foster; Constantine G Haidaris
Journal:  Photochem Photobiol       Date:  2011-12-20       Impact factor: 3.421

2.  Immunization with the Candida albicans membrane fraction and in combination with fluconazole protects against systemic fungal infections.

Authors:  S Mizutani; M Endo; T Ino-Ue; M Kurasawa; Y Uno; H Saito; I Kato; K Takesako
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

3.  Acetate-mediated growth inhibition in sterol 14alpha-demethylation-deficient cells of Candida albicans.

Authors:  O Shimokawa; H Nakayama
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

Review 4.  Antifungal agents: chemotherapeutic targets and immunologic strategies.

Authors:  N H Georgopapadakou; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

Review 5.  Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.

Authors:  T C White; K A Marr; R A Bowden
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

Review 6.  Mechanisms of Candida biofilm drug resistance.

Authors:  Heather T Taff; Kaitlin F Mitchell; Jessica A Edward; David R Andes
Journal:  Future Microbiol       Date:  2013-10       Impact factor: 3.165

7.  Hydrogen peroxide induced by the fungicide prothioconazole triggers deoxynivalenol (DON) production by Fusarium graminearum.

Authors:  Kris Audenaert; Elien Callewaert; Monica Höfte; Sarah De Saeger; Geert Haesaert
Journal:  BMC Microbiol       Date:  2010-04-15       Impact factor: 3.605

8.  Sterol synthesis and viability of erg11 (cytochrome P450 lanosterol demethylase) mutations in Saccharomyces cerevisiae and Candida albicans.

Authors:  M Bard; N D Lees; T Turi; D Craft; L Cofrin; R Barbuch; C Koegel; J C Loper
Journal:  Lipids       Date:  1993-11       Impact factor: 1.880

9.  Effect of granulocyte colony-stimulating factor combination therapy on efficacy of posaconazole (SCH56592) in an inhalation model of murine pulmonary aspergillosis.

Authors:  Andriani C Patera; Frederick Menzel; Craig Jackson; Joan K Brieland; Judy Halpern; Roberta Hare; Anthony Cacciapuoti; David Loebenberg
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

10.  Antagonistic effects of fluconazole and 5-fluorocytosine on candidacidal action of amphotericin B in human serum.

Authors:  E Martin; F Maier; S Bhakdi
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.